4 August 2020 - Consultation has gone out today to health professionals and is available on PHARMAC’s website for anyone ...
10 July 2020 - The central task of cost-effectiveness analysis is to identify strategies that maximise health within finite budgets. ...
10 July 2020 - The incremental cost-effectiveness ratio (ICER) is the most commonly reported summary measure for economic evaluations of health ...
1 July 2020 - When setting priorities for health, there is broad agreement that a range of social values and ethical ...
19 June 2020 - Medicines New Zealand is today launching a digitally-enabled public awareness platform Fairness in Focus. ...
17 June 2020 - The Trump Administration has delivered significant policy advancements to lower the price of drugs and spur greater ...
11 June 2020 - FDA’s recent benefit‐risk framework was developed for improving the clarity and consistency in communicating the reasoning behind ...
5 June 2020 - The review was published on the PHARMAC website today and shared with people who had been ...
2 June 2020 - Innovative medical products offer significant and potentially transformative impacts on health, but they create concerns about rising ...
1 June 2020 - Cost effectiveness analyses, which are often conducted to evaluate new medicines, use a standardised framework to ...
20 May 2020 - Andrew Rintoul and colleagues argue that collaboration and transparency increase the market power of buyers who ...
11 May 2020 - Trade-offs are routine in health policy, and the math and analysis underlying them have been around for ...
15 May 2020 - Regulators are highlighting the need for a comprehensive international coordination mechanism to allow the conduct of ...
7 May 2020 - Health technology assessment recommendations informed by patient concerns are seen to ensure democracy and legitimacy. ...
23 April 2020 - In April 2020, PHARMAC convened a group of clinical experts from across New Zealand for an ...